Literature DB >> 8100821

Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas.

M Volm1, P Drings, W Wodrich.   

Abstract

The expression of the oncogenes c-fos, c-jun, c-myc, c-erbB-1 and c-erbB-2 at the protein level was analyzed in squamous cell lung carcinomas of 121 patients by means of immunohistochemistry. Patients with overexpression of proteins encoded by the oncogenes c-fos, c-jun and c-erbB-1 had significantly shorter survival times than these without overexpression of these oncogene products (c-fos: p = 0.009; c-jun: p = 0.029; c-erbB-1: p = 0.018). No significant correlations were found between the expression of c-myc and c-erbB-2 products and the survival of the patients. In addition to the univariate analyses (Kaplan-Meier-estimates) multivariate analyses (Cox-regression-model) revealed that protein expression of the oncogenes c-fos, c-jun and c-erbB-1 are significant prognostic factors in addition to staging.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8100821     DOI: 10.1007/bf01686458

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  18 in total

1.  A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.

Authors:  E A GEHAN
Journal:  Biometrika       Date:  1965-06       Impact factor: 2.445

2.  Immunocytochemical detection of a resistance-associated glycoprotein in tissue culture cells, ascites tumors and human tumor xenografts by Mab 265/F4.

Authors:  M Volm; M Bak; T Efferth; B Lathan; J Mattern
Journal:  Anticancer Res       Date:  1988 Jul-Aug       Impact factor: 2.480

3.  Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.

Authors:  M J van de Vijver; J L Peterse; W J Mooi; P Wisman; J Lomans; O Dalesio; R Nusse
Journal:  N Engl J Med       Date:  1988-11-10       Impact factor: 91.245

4.  Expression of ras p21 and myc p62 oncoproteins in small cell and non small cell carcinoma of the lung.

Authors:  D A Spandidos; S Zakinthinos; C Petraki; F Sotsiou; M Yiagnisis; A M Dimopoulos; C Roussos; J K Field
Journal:  Anticancer Res       Date:  1990 Sep-Oct       Impact factor: 2.480

5.  Overexpression of C-fos and C-erbb1 encoded proteins in squamous-cell carcinomas of the lung of smokers.

Authors:  M Volm; T Efferth; J Mattern; W Wodrich
Journal:  Int J Oncol       Date:  1992-06       Impact factor: 5.650

Review 6.  The molecular genetics of human lung cancer.

Authors:  R J Slebos; S Rodenhuis
Journal:  Eur Respir J       Date:  1989-05       Impact factor: 16.671

7.  Detection of fos protein during osteogenesis by monoclonal antibodies.

Authors:  P De Togni; H Niman; V Raymond; P Sawchenko; I M Verma
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

8.  Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations.

Authors:  M Volm; T Efferth; J Mattern
Journal:  Anticancer Res       Date:  1992 Jan-Feb       Impact factor: 2.480

9.  p185neu expression in human lung adenocarcinomas predicts shortened survival.

Authors:  J A Kern; D A Schwartz; J E Nordberg; D B Weiner; M I Greene; L Torney; R A Robinson
Journal:  Cancer Res       Date:  1990-08-15       Impact factor: 12.701

Review 10.  The pathologist and the clinical oncologist: a new effective partnership in assessing tumor prognosis.

Authors:  G Saccani Jotti; G Bonadonna
Journal:  Eur J Cancer Clin Oncol       Date:  1989-04
View more
  25 in total

1.  Knockdown of c-Fos suppresses the growth of human colon carcinoma cells in athymic mice.

Authors:  Manoj K Pandey; Guangming Liu; Timothy K Cooper; Kathleen M Mulder
Journal:  Int J Cancer       Date:  2011-04-08       Impact factor: 7.396

2.  Regulation of activator protein-1 activity in the mediastinal lymph node metastasis of lung cancer.

Authors:  K Ichiki; N Mitani; Y Doki; H Hara; T Misaki; I Saiki
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

3.  Survival impact of epidermal growth factor receptor overexpression in patients with non-small cell lung cancer: a meta-analysis.

Authors:  H Nakamura; N Kawasaki; M Taguchi; K Kabasawa
Journal:  Thorax       Date:  2005-11-11       Impact factor: 9.139

4.  Cigarette Smoke Mediates Nuclear to Cytoplasmic Trafficking of Transcriptional Inhibitor Kaiso through MUC1 and P120-Catenin.

Authors:  Lili Zhang; Marianne Gallup; Lorna Zlock; Yu Ting Feeling Chen; Walter E Finkbeiner; Nancy A McNamara
Journal:  Am J Pathol       Date:  2016-10-17       Impact factor: 4.307

5.  A dominant-negative c-jun mutant inhibits lung carcinogenesis in mice.

Authors:  Jay W Tichelaar; Ying Yan; Qing Tan; Yian Wang; Richard D Estensen; Matthew R Young; Nancy H Colburn; Hulian Yin; Colleen Goodin; Marshall W Anderson; Ming You
Journal:  Cancer Prev Res (Phila)       Date:  2010-08-17

Review 6.  Strategies for Improving Photodynamic Therapy Through Pharmacological Modulation of the Immediate Early Stress Response.

Authors:  Daniel J de Klerk; Mark J de Keijzer; Lionel M Dias; Jordi Heemskerk; Lianne R de Haan; Tony G Kleijn; Leonardo P Franchi; Michal Heger
Journal:  Methods Mol Biol       Date:  2022

7.  Optimal Objective-Based Experimental Design for Uncertain Dynamical Gene Networks with Experimental Error.

Authors:  Daniel N Mohsenizadeh; Roozbeh Dehghannasiri; Edward R Dougherty
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2016-08-25       Impact factor: 3.710

8.  Analysis of c-fos, c-jun, c-erbB1, c-erbB2 and c-myc in primary lung carcinomas and their lymph node metastases.

Authors:  M Volm; G van Kaick; J Mattern
Journal:  Clin Exp Metastasis       Date:  1994-07       Impact factor: 5.150

9.  Epidermal growth factor receptor (EGFR) expression in operable non-small cell lung carcinoma.

Authors:  Jin-Hee Ahn; Sang-We Kim; Seung-Mo Hong; Cheolwon Suh; Woo Kun Kim; In Chul Lee; Jung-Shin Lee
Journal:  J Korean Med Sci       Date:  2004-08       Impact factor: 2.153

10.  Prognostic value of epidermal growth factor receptor expression in operable non-small cell lung carcinoma.

Authors:  Ekrem Cengiz Seyhan; Sedat Altın; Erdogan Cetinkaya; Sinem Sökücü; Hülya Abalı; Nur Buyukpinarbasili; Neslihan Fener
Journal:  Multidiscip Respir Med       Date:  2010-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.